Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clearside Biomedical Inc.

    NASDAQ: CLSD · Real-Time Price · USD
    0.80
    0.00 (0.44%)
    At close: Jun 17, 2025, 10:30 AM
    0.44%
    Bid 0.79
    Market Cap 61.85M
    Revenue (ttm) 1.43M
    Net Income (ttm) -30.81M
    EPS (ttm) -0.41
    PE Ratio (ttm) -1.94
    Forward PE -1.34
    Analyst Buy
    Ask 0.8
    Volume 11,867
    Avg. Volume (20D) 234,379
    Open 0.79
    Previous Close 0.80
    Day's Range 0.79 - 0.80
    52-Week Range 0.70 - 1.65
    Beta 2.06

    About CLSD

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CLSD
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CLSD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    +14.82%
    Clearside Biomedical shares are trading higher aft... Unlock content with Pro Subscription
    news image

    2 weeks ago · zacks.com

    Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know

    Clearside Biomedical (CLSD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    news image

    1 month ago · zacks.com

    Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates

    Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.17 per share a year ago.

    news image

    1 month ago · zacks.com

    Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know

    Clearside Biomedical (CLSD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · seekingalpha.com

    Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript

    Clearside Biomedical, Inc. (NASDAQ:CLSD ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Jenny Kobin - IR George Lasezkay - CEO Victor Chong - Chief Medical Officer Ch...

    news image

    2 months ago · zacks.com

    Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates

    Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.08 per share a year ago.

    Add to Watchlist